BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 16753022)

  • 1. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo.
    Kulkarni NH; Onyia JE; Zeng Q; Tian X; Liu M; Halladay DL; Frolik CA; Engler T; Wei T; Kriauciunas A; Martin TJ; Sato M; Bryant HU; Ma YL
    J Bone Miner Res; 2006 Jun; 21(6):910-20. PubMed ID: 16753022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human stem cell osteoblastogenesis mediated by novel glycogen synthase kinase 3 inhibitors induces bone formation and a unique bone turnover biomarker profile in rats.
    Gilmour PS; O'Shea PJ; Fagura M; Pilling JE; Sanganee H; Wada H; Courtney PF; Kavanagh S; Hall PA; Escott KJ
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):399-407. PubMed ID: 23872097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoride promotes osteoblastic differentiation through canonical Wnt/β-catenin signaling pathway.
    Pan L; Shi X; Liu S; Guo X; Zhao M; Cai R; Sun G
    Toxicol Lett; 2014 Feb; 225(1):34-42. PubMed ID: 24300170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK-3 inhibition by an orally active small molecule increases bone mass in rats.
    Marsell R; Sisask G; Nilsson Y; Sundgren-Andersson AK; Andersson U; Larsson S; Nilsson O; Ljunggren O; Jonsson KB
    Bone; 2012 Mar; 50(3):619-27. PubMed ID: 22142634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
    Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
    Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor.
    Kulkarni NH; Wei T; Kumar A; Dow ER; Stewart TR; Shou J; N'cho M; Sterchi DL; Gitter BD; Higgs RE; Halladay DL; Engler TA; Martin TJ; Bryant HU; Ma YL; Onyia JE
    J Cell Biochem; 2007 Dec; 102(6):1504-18. PubMed ID: 17520664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
    Amirhosseini M; Madsen RV; Escott KJ; Bostrom MP; Ross FP; Fahlgren A
    J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.
    Gambardella A; Nagaraju CK; O'Shea PJ; Mohanty ST; Kottam L; Pilling J; Sullivan M; Djerbi M; Koopmann W; Croucher PI; Bellantuono I
    J Bone Miner Res; 2011 Apr; 26(4):811-21. PubMed ID: 20939016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of Liuwei Dihuang on canonical Wnt/β-catenin signaling pathway in osteoporosis.
    Xia B; Xu B; Sun Y; Xiao L; Pan J; Jin H; Tong P
    J Ethnopharmacol; 2014 Apr; 153(1):133-41. PubMed ID: 24530448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of bone formation in the expanding premaxillary suture with a GSK-3β inhibitor.
    Jiang Y; Liu HX; Guo JJ; Tang GH; Qian YF
    Oral Dis; 2013 Jan; 19(1):73-9. PubMed ID: 22776263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceleration of bone regeneration by local application of lithium: Wnt signal-mediated osteoblastogenesis and Wnt signal-independent suppression of osteoclastogenesis.
    Arioka M; Takahashi-Yanaga F; Sasaki M; Yoshihara T; Morimoto S; Hirata M; Mori Y; Sasaguri T
    Biochem Pharmacol; 2014 Aug; 90(4):397-405. PubMed ID: 24955980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stretch-induced inhibition of Wnt/beta-catenin signaling in mineralizing osteoblasts.
    Jansen JH; Eijken M; Jahr H; Chiba H; Verhaar JA; van Leeuwen JP; Weinans H
    J Orthop Res; 2010 Mar; 28(3):390-6. PubMed ID: 19780202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin promotes osteoblast differentiation and mineralization of primary cultures of vascular smooth muscle cells by inhibiting glycogen synthase kinase (GSK)-3β.
    Zeadin MG; Butcher MK; Shaughnessy SG; Werstuck GH
    Biochem Biophys Res Commun; 2012 Sep; 425(4):924-30. PubMed ID: 22906741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
    Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
    FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guava fruit extract and its triterpene constituents have osteoanabolic effect: Stimulation of osteoblast differentiation by activation of mitochondrial respiration via the Wnt/β-catenin signaling.
    Porwal K; Pal S; Dev K; China SP; Kumar Y; Singh C; Barbhuyan T; Sinha N; Sanyal S; Trivedi AK; Maurya R; Chattopadhyay N
    J Nutr Biochem; 2017 Jun; 44():22-34. PubMed ID: 28343085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKR plays a positive role in osteoblast differentiation by regulating GSK-3β activity through a β-catenin-independent pathway.
    Yoshida K; Okamura H; Ochiai K; Hoshino Y; Haneji T; Yoshioka M; Hinode D; Yoshida H
    Mol Cell Endocrinol; 2012 Sep; 361(1-2):99-105. PubMed ID: 22484461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
    Georgiou KR; King TJ; Scherer MA; Zhou H; Foster BK; Xian CJ
    Bone; 2012 Jun; 50(6):1223-33. PubMed ID: 22484100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for ethanol-induced oxidative stress in controlling lineage commitment of mesenchymal stromal cells through inhibition of Wnt/beta-catenin signaling.
    Chen JR; Lazarenko OP; Shankar K; Blackburn ML; Badger TM; Ronis MJ
    J Bone Miner Res; 2010 May; 25(5):1117-27. PubMed ID: 20200986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.